Yuval Naot to Humans
This is a "connection" page, showing publications Yuval Naot has written about Humans.
Connection Strength
0.007
-
A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer. Clin Breast Cancer. 2010 Oct 01; 10(5):367-72.
Score: 0.004
-
Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site. Oncologist. 2009 Dec; 14(12):1189-97.
Score: 0.003